The Company is pleased to announce that on 21 July 2009, the Company, through its indirect wholly-owned subsidiary, Anping Technology, entered into the Business Operating Agreement with Wuhu Longyuan and Yingtan Boken, pursuant to which Anping Technology will become the exclusive provider of the Management Services in respect of Renji Radiotherapy Centre and entitle to the Attributable Net Income for a term of 16 years (with an option to extend for 20 additional years at the discretion of Anping Technology). The Group, in return, will issue 1,950,000,000 Consideration Shares to Wuhu Longyuan (which amounted to approximately HK$128.70 million based on the closing price of the Company’s shares of HK$0.066 as at the date of this announcement) as consideration under the Business Operating Agreement. The Group has also entered into an asset pledge agreement, pursuant to which, Wuhu Longyuan has pledged its 70% interest in the assets (mainly medical equipment) at Renji Radiotherapy Centre to the Group during the initial term of the Business Operating Agreement in order to secure the obligations of Wuhu Longyuan under the Business Operating Agreement. The 1,950,000,000 Consideration Shares will be issued under the General Mandate and an application will be made by the Company to The Hong Kong Stock Exchange Limited for the listing of, and the permission to deal in, the Consideration Shares.
|